Dupixent approved in EU as targeted therapy for COPD: Sanofi, Regeneron Pharma Ruchika Sharma3 July 2024 2:00 PM ISTParis: Sanofi and Regeneron Pharmaceuticals has announced that the European Medicines Agency (EMA) has approved Dupixent (dupilumab) as...
Eli Lilly Kisunla gets USFDA okay for early Symptomatic Alzheimer's Disease Ruchika Sharma3 July 2024 11:20 AM ISTIndianapolis: Eli Lilly has announced that the U.S. Food and Drug Administration (FDA) has approved Alzheimer's treatment Kisunla...
Lynparza, Imfinzi combo recommended for nod in EU by CHMP for endometrial cancer: AstraZeneca Ruchika Sharma3 July 2024 10:00 AM ISTCambridge: AstraZeneca has announced that Imfinzi (durvalumab) and Lynparza (olaparib) have been recommended for approval in the European Union (EU)...
Marksans Pharma arm bags UKMHRA marketing authorization for Rasagiline Relonchem, Olmesartan tablets Ruchika Sharma2 July 2024 5:13 PM ISTMumbai: Marksans Pharma has announced that its wholly-owned subsidiary Relonchem Limited has received Marketing Authorization from UKMHRA...
Sanofi plans up to USD 1.6 billion investment in Germany: Handelsblatt Ruchika Sharma2 July 2024 2:50 PM ISTFrankfurt: French pharmaceutical company, Sanofi, is close to deciding on an investment ranging between 1.3 billion euros and 1.5 billion euros...
KKR buys controlling stake in Baby Memorial Hospital Ruchika Sharma2 July 2024 12:13 PM ISTMumbai: Global investment firm, KKR, will acquire a controlling stake in Baby Memorial Hospital, a regional multi-specialty hospital chain in...
Indian health insurer Niva Bupa files for Rs 3000 crore IPO Ruchika Sharma2 July 2024 11:30 AM ISTBengaluru: Niva Bupa, an Indian health insurer, has filed for an initial public offering (IPO) aiming to raise up to 30 billion rupees...
Sipavibart EMA regulatory submission accepted under accelerated assessment for COVID 19 prevention: AsraZeneca Ruchika Sharma1 July 2024 5:33 PM ISTCambridge: AstraZeneca's Marketing Authorisation Application (MAA) for sipavibart has been accepted under an accelerated assessment procedure by...
CDSCO Panel Approves AstraZeneca pharma's Protocol Amendment proposal to study Anifrolumab Dr. Divya Colin1 July 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the drug major...
Perindopril case: Lupin to pay Euro 40 million fine to European Commission Ruchika Sharma1 July 2024 2:30 PM ISTThe European Court of Justice has upheld the European Commission's decision to impose a Euro 40 million fine on Lupin Limited. This penalty arises...
Another man held over fake medicine racket busted in Nagpur district Ruchika Sharma1 July 2024 12:30 PM ISTNagpur: A man has been arrested from Saharanpur, UP in connection with a counterfeit medicine racket busted in March 2023. The official mentioned...
Alembic Pharma bags USFDA tentative nod for Bosutinib Tablets to treat certain type of leukemia Ruchika Sharma1 July 2024 11:27 AM ISTBosutinib tablets are indicated for the treatment of a certain type of leukemia called Philadelphia chromosome-positive chronic myelogenous leukemia.
